SCN1A, SCN2A, SCN3A, SCN8A, SCN9A, SCN11A, and SCN1B sodium channel gene mutations were intimately associated with epilepsy and displayed significant heterogeneity in pathogenesis and clinical symptoms. This evidence concerns the gene SCN3A and epilepsy.